Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molibresib with Chemotherapy in NUT Carcinoma
NCT04116359Phase 2Withdrawn
- Sponsor
- National Cancer Institute
- Start
- Sep 2020
- Primary completion
- Sep 2020
- Modality
- Allosteric Modulators
01
Overview
A Phase 2 trial of molibresib in NUT carcinoma (NC), sponsored by National Cancer Institute. Planned start Sep 2020; status: withdrawn.
02
Drugs
molibresib
03
Conditions
NUT carcinoma (NC)
Beyond the preview
Go deeper on NCT04116359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04116359.